|
|
|
| Monday,
November 15th |
|
|
|
|
|
08.30-08.45 |
Welcome address and introduction to day 1
Nils
Wahlgren, Stockholm |
|
|
08.45-09.55 |
Session: Carotid artery
stenosis
Chairpersons: Charles
Warlow, Edinburgh, and Thomas Mätzsch, Malmö
|
|
|
08.45-09.05 |
Surgery in asymptomatic
carotid stenosis
Allison Halliday, London |
|
|
09.05-09.25 |
Stenting for carotid artery
stenosis
Michael Hennerici, Mannheim
|
|
|
09.25-09.40 |
Critical analysis
Jesper Swedenborg, Stockholm |
|
|
09.40-09.55 |
Consensus discussion and
statement
|
|
|
09.55-10.25 |
Coffee break |
|
|
10.25-10.55 |
Special lecture:
On Stroke, handedness and
sudden death
Vladimir Hachinski, London,
Ontario |
|
|
10.55-12.10 |
Session: Antiplatelet therapy
Chairpersons: Bo Norrving,
Lund, and Juhani Sivenius, Kuopio |
|
|
10.55-11.15 |
After the
MATCH and CARESS studies:
Conclusions for clopidogrel in secondary stroke
prevention?
Christoph Diener, Essen |
|
|
11.15-11.25 |
Cost-effectiveness of
antiplatelet therapies: a summary of a recent NICE-report
Bo Norrving, Lund
|
|
|
11.25-11.40 |
Risk for recurrent events in
the early phase of stroke. Implications for antiplatelet
strategy.
Laszlo Csiba, Debrecen |
|
|
11.40-11.55 |
Which antiplatelet when? Tentative model for selection
of antiplatelet agent
Natan Bornstein, Tel Aviv |
|
|
11.55-12.10 |
Consensus discussion and
statement
|
|
|
12.10-13.10 |
Lunch and poster exhibition
|
|
|
13.10-14.30 |
Session: Blood pressure
control and secondary stroke prevention
Chairpersons: Eivind Berge,
Oslo, and Andreas Terent, Uppsala |
|
|
13.10-13.30 |
The case for angiotensin II
antagonists
Björn Dahlöf, Göteborg |
|
|
13.30-13.50 |
The case for
angiotensin-converting enzyme inhibitors (ACE inhibitors)
Kennedy R Lees, Glasgow
|
|
|
13.50-14.10 |
Suggested updated model for blood pressure lowering
Andreas Terent, Uppsala |
|
|
14.10-14.25 |
Low blood pressure in the
elderly is related to dementia
Laura Fratiglione,
Stockholm
|
|
|
14.25-14.40 |
Consensus discussion and
statement (including a short presentation of the SCAST study
by Eivind Berge, Oslo) |
|
|
14.40-15.10 |
Coffee break
(SCAST study investigators
meeting in room 354)
|
|
|
15.10-16.25 |
Session: Other issues in secondary
stroke prevention
Chairpersons: Per Wester,
Umeå,
and Anna Czlonkowska, Warsaw |
|
|
15.10-15.30 |
Statins
for secondary stroke prevention
Pierre Amarenco, Paris
|
|
|
15.30-15.50 |
Thrombin inhibitors: What can
we learn from SPORTIF
III and SPORTIF V: Ximelagatran vs warfarin?
Gudrun Boysen, Copenhagen |
|
|
15.50-16.10 |
Critical
comment
Danilo Toni, Rome |
|
|
16.10-16.25 |
Consensus discussion and
statement
|
|
|
16.25-16.30 |
Summary and closing of the first day of the meeting
Nils Wahlgren, Stockholm |
|
|
16.30 |
Transport to Stockholm Concert
Hall, Grünewald Room |
|
|
17.00-17.15 |
Stockholm Academic Male Chorus |
|
|
17.15-17.45 |
Karolinska Stroke Award
2004 - for Excellence in Stroke Research |
|
|
17.45-18.30 |
Guided tour at Stockholm Concert
Hall |
|
|
19.30 |
Dinner
at Grand Hotel Royal Winter Garden |
|
|
|
|
|
|
Tuesday,
November 16th |
|
|
|
|
|
|
08.30-08.35 |
Introduction
to day
2
|
|
|
08.35-09.15 |
Ongoing trials update: Acute
stroke
Veronika Skvortsova, Moscow, and Hans-Göran Hårdemark, Uppsala
|
|
|
08.35-08.55 |
Acute stroke trials
Werner Hacke, Heidelberg |
|
|
08.55-09.15 |
Update on cooling in acute
stroke
Jesper Petersson, Malmö |
|
|
09.15-10.20 |
Session: Management of
cerebral haemorrhage in the perspective of new clinical
trials data
Chairpersons: Werner Hacke,
Heidelberg, and Hubert Kwiecinski, Warsaw
|
|
|
09.15-09.35 |
Medical management of cerebral
haemorrhage - do we now have a new treatment for
haemorrhagic stroke?
Thorsten Steiner,
Heidelberg
|
|
|
09.35-09.50 |
Surgical treatment of cerebral
haemorrhage - conclusions from STICH
David Mendelow, Newcastle
|
|
|
09.50-10.05 |
Critical analysis of study
data
Charles Warlow, Edinburgh |
|
|
10.05-10.20 |
Consensus discussion and
statement
|
|
|
10.20-10.50 |
Coffee break |
|
|
10.50-12.15 |
Session: Reperfusion in acute
occlusive stroke
Chairpersons: Markku Kaste,
Helsinki and Kennedy R Lees, Glasgow
|
|
|
10.50-11.10 |
Pooled analysis of data from
randomised controlled trials of rt-PA in acute stroke
Cesare Fieschi, Rome
|
|
|
11.10-11.25 |
Factors influencing door to
needle time
Geert Vanhooren, Brûgge
|
|
|
11.25-11.40 |
SITS:
Experience from i.v. thrombolysis
in clinical routine
Nils Wahlgren, Stockholm
|
|
|
11.40-12.00 |
Intraarterial thrombolysis and
endovascular recanalization for acute stroke
Heinrich Mattle, Bern
|
|
|
12.00-12.15 |
Consensus discussion and
statement
|
|
|
12.15-13.15 |
Lunch and poster exhibition
|
|
|
13.15-13.45 |
Special lecture: Biases in
randomised controlled trials
Charles Warlow, Edinburgh
|
|
|
13.45-15.00 |
Session:
The impact of imaging on stroke treatment and
clinical outcome.
Rüdiger von Kummer, Dresden,
and Wolf Dieter Heiss, Cologne |
|
|
13.45-14.05 |
Imaging
in acute stroke: The case for computer tomography
Rüdiger von Kummer, Dresden
|
|
|
14.05-14.25 |
Imaging
in acute stroke: The case for magnetic resonance tomograhy
and positron emission tomography
Wolf Dieter Heiss, Cologne
|
|
|
14.25-14.45 |
Perfusion-CT and
CT-angiography before i.v. thrombolysis
Patrik Michel, Lausanne
|
|
|
14.45-15.00 |
Consensus discussion and
statement
|
|
|
15.00-15.30 |
Coffee break |
|
|
15.30-16.45 |
Session:
Stroke
Management
Michael Brainin,
Vienna, and Zoltan Nagy, Budapest
|
|
|
15.30-15.50 |
Prevention of deep venous thrombosis - what to do with
conflicting guidelines?
Per Morten Sandset, Oslo |
|
|
15.50-16.10 |
Management
of blood pressure, blood glucose and body temperature in
acute stroke
Hanne Christensen,
Copenhagen |
|
|
16.10-16.30 |
Can dementia following stroke
be prevented?
Didier Leys, Lille
|
|
|
16.30-16.45 |
Consensus discussion and
statement
|
|
|
16.45-17.00 |
Summary
and closing of the meeting
Nils G Wahlgren, Stockholm |
|